Shah Jatin
Insider CIK 1782186 · KPTI EVP, Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-17 | 2022-02-22 | 1,306 | $12.12 | $15.8K | 129,450 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-07 | 2022-02-09 | 1,704 | $9.86 | $16.8K | 130,756 | SEC↗ |
| KPTI Karyopharm Therapeutics In | F Tax w/h | 2021-07-12 | 2021-07-13 | 665 | $9.73 | $6.5K | 131,137 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2021-05-07 | 2021-05-11 | 23,250 | $8.60 | $199.9K | 131,802 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-02-25 | 2021-03-01 | 59,968 | — | $0 | 59,968 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2021-02-25 | 2021-03-01 | 22,013 | — | $0 | 107,691 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-18 | 2021-02-22 | 1,186 | $14.83 | $17.6K | 51,791 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-15 | 2021-02-17 | 4,850 | — | $0 | 9,700 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-15 | 2021-02-17 | 4,850 | — | $0 | 52,977 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-11 | 2021-02-17 | 1,748 | $15.52 | $27.1K | 48,127 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-05 | 2021-02-09 | 5,650 | — | $0 | 16,950 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-05 | 2021-02-09 | 5,650 | — | $0 | 49,875 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-07-15 | 2020-11-04 | 589 | $19.46 | $11.5K | 43,229 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-07-11 | 2020-11-04 | 2,413 | — | $0 | 7,237 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-07-11 | 2020-11-04 | 2,413 | — | $0 | 43,172 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-02-19 | 2020-02-21 | 1,375 | $16.48 | $22.7K | 40,759 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-02-15 | 2020-02-19 | 4,850 | — | $0 | 14,550 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-02-15 | 2020-02-19 | 4,850 | — | $0 | 42,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 22,600 | — | $0 | 22,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 60,600 | — | $0 | 60,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-07-11 | 2019-07-15 | 9,650 | — | $0 | 9,650 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-07-11 | 2019-07-15 | 25,700 | — | $0 | 25,700 | SEC↗ |